217
199
172
142
115
80
177
134
97
76
54
40
SC
events 3y 5y N
low risk
36
87% 82% 217
high risk 58
69% 62% 177
Log Rank test
p≤0.001
istant control in consecutive patients treated with radiochemotherapy
Months
Actuarial probability
38%
18%
Low risk: 1B, 2A, 2B, 3A &N0,
High risk: 2A-2B&N+, any3B4
RetroEMBRACE Outcome Sturdza et al. 2015
(unpublished)